The mainstream copper-biology research community and the broader peptide research community have engaged with the GHK-Cu literature at various points, but the depth of independent characterization outside the Pickart-affiliated research has been variable
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
These are the same mechanisms that make Minoxidil effective, but through a different pathway, as research published in the Journal of Biomaterials Science documenting GHK-Cus ability to stimulate hair follicle size, strengthen the dermal papilla, and promote angiogenesis confirmed
Purity and quality are guaranteed for research purposes only
However, glutathione is not without its controversies or risks
In reaction to Sermorelin, the pituitary gland releases growth hormone